title: Triglycerides and heart disease: still a hypothesis?
abstract: The purpose of this article is to review the basic and clinical science relating plasma triglycerides and cardiovascular disease. Although many aspects of the basic physiology of triglyceride production, its plasma transport, and its tissue uptake have been known for several decades, the relationship of plasma triglyceride levels to vascular disease is uncertain. Are triglyceride-rich lipoproteins, their influence on high-density lipoprotein and low-density lipoprotein, or the underlying diseases that lead to defects in triglyceride metabolism the culprit? Animal models have failed to confirm that anything other than early fatty lesions can be produced by triglyceride-rich lipoproteins. Metabolic products of triglyceride metabolism can be toxic to arterial cells; however, these studies are primarily in vitro. Correlative studies of fasting and postprandial triglycerides and genetic diseases implicate very-low-density lipoprotein and their remnants and chylomicron remnants in atherosclerosis development, but the concomitant alterations in other lipoproteins and other risk factors obscure any conclusions about direct relationships between disease and triglycerides. Genes that regulate triglyceride levels also correlate with vascular disease. Human intervention trials, however, have lacked an appropriately defined population and have produced outcomes without definitive conclusions. The time is more than ripe for new and creative approaches to understanding the relationship of triglycerides and heart disease.
authors.affiliation: Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. ijg3@columbia.edu
authors.forename: Ira J
authors.initials: IJ
authors.lastname: Goldberg
authors.forename: Robert H
authors.initials: RH
authors.lastname: Eckel
authors.forename: Ruth
authors.initials: R
authors.lastname: McPherson
mesh_terms: D000818:Animals; D050197:Atherosclerosis / Q000097:blood / Q000209:etiology; D001693:Biological Transport, Active; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology / Q000517:prevention & control; D002914:Chylomicrons / Q000378:metabolism; D002986:Clinical Trials as Topic; D055106:Genome-Wide Association Study; D006331:Heart Diseases / Q000097:blood* / Q000209:etiology*; D006801:Humans; D015228:Hypertriglyceridemia / Q000188:drug therapy; D008066:Lipolysis; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008955:Models, Cardiovascular; D014280:Triglycerides / Q000097:blood* / Q000235:genetics / Q000378:metabolism
chemical_list: D002914:Chylomicrons; D008074:Lipoproteins; D014280:Triglycerides